In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Michael Kurr, a global transformation leader with 15+ years building large-scale commercial and medical affairs operations at Novartis and Boehringer Ingelheim, on what delivery at scale actually looks like in the AI era.
Michael built content and delivery organizations of over 1,000 people — and he has some of the most direct takes on where pharma transformation is stalling.
Key takeaways:
Modular content served its purpose as a scalability crutch — but well-trained AI models will eventually make it obsolete
MLR is a bottleneck not just because of technology, but because of trust — local approvers carry legal liability and need confidence in what they sign off
AI systems must become more explainable and deterministic before pharma can rely on AI-generated and AI-approved content
The King Kong principle: having content is the easier part — getting the right content to the right customer at the right time, at scale, is the real challenge
Staying relevant and staying current is the only viable strategy for individuals navigating AI-driven transformation
📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)
Podden och tillhörande omslagsbild på den här sidan tillhör
Nataliya Andreychuk. Innehållet i podden är skapat av Nataliya Andreychuk och inte av,
eller tillsammans med, Poddtoppen.
